Simple Summary Immunotherapy helps a person's immune system to target tumor cells.
Recent advances in cancer immunotherapy, including immune checkpoint inhibition …

The recent clinical successes of immune checkpoint blockade and chimeric antigen receptor
T cell therapies represent a turning point in cancer immunotherapy. These successes also …

Recent advances in cancer immunology have enabled the discovery of promising
immunotherapies for various malignancies that have shifted the cancer treatment paradigm …

For many years, immunotherapeutic approaches for cancer held more promise than actual
clinical benefit for the majority of patients. However, several recent key advances in tumor …

The remarkable specificity of the immune system through antigen recognition has long
attracted investigators to the possibility of immune-based therapy for cancer. Previous …

Recent scientific advances have expanded our understanding of the immune system and its
response to malignant cells. The clinical goal of tumour immunotherapy is to provide either …

Background The main goal of anti-cancer therapy is to specifically inhibit the malignant
activity of cancer cells, while leaving healthy cells unaffected. As such, for every proposed …

Immunotherapy of cancer is entering into a new phase of active investigation both at the pre-
clinical and clinical level. This is due to the exciting developments in basic immunology and …

Cancer immunotherapy is demonstrating impressive clinical benefit in different malignancies
and clinical oncologists are increasingly turning their attention to immune-oncology. It is now …

Cancer is a worldwide medical problem with significant repercussions on individual patients
and societies as a whole. In order to alter the outcomes of this deadly disease the treatment …